Oraverse Versus Laser

sara nabil40 enrolled

Overview

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse

Patients will be divided randomly into two groups (20 patients in each group) Group (1): Patients will be undergoing anesthesia revision by diode laser Group (2): Patients will be undergoing anesthesia revision by oraverse. Then each group will be subdivided into 2 subgroups (10 patients each) according to type of local anesthetic agent into: subgroup 1: Articaine 4% with 1:100000 epinephrin \&Subgroup 2: Articaine 4% with 1:200000 epinephrin After 30 min of injection corresponding to approximate time of treatment, the patient in each group will be exposed to the reversal agent which may be diode laser or oraverse.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Reversal of Local Anesthesia in Children

Interventions

OraVerse Injectable ProductDRUG

injection of oraverse,

diode laserDEVICE

patient exposed to diode laser

Eligibility

Sex: ALLMin age: 6 YearsMax age: 10 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients who need to be treated under anesthesia by injecting mandibular first molar infiltration. 2. Cooperative children aged 6 to 10 years old with the ability to understand and respond to the sensation of soft tissue -

Locations (1)

Dr.sara nabil

Cairo, Egypt

RECRUITING

Outcomes

Primary Outcomes

reversal of local anasthesia

patient free of lip numbness

Time frame: 30 minute

Central Contacts

sara nabil, DR

CONTACT

00201006420998 snhasem@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.